Product Wiki · Recalls · Health Canada — Marketed Health Products

ZOFRAN (ondansetron) — recall 25707

Health Canada — Marketed Health Products · Canada · 2012-10-09

As described by Health Canada — Marketed Health Products: ZOFRAN (ondansetron) - Association with Changes in Electrical Activity in the Heart - For Health Professionals

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Marketed Health Products
Recall identifier
25707
Date of alert
2012-10-09
Country / jurisdiction
Canada
Risk type
recall
Product category
Drugs
Product type
Marketed health products
Notice status
Archived by the issuing authority — kept for reference
Reported risk: ZOFRAN ® (ondansetron hydrochloride dihydrate, ondansetron) - Important new safety information: Dose restriction for intravenous (IV) use due to dose-dependent QT interval prolongation
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/zofran-ondansetron-association

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.